DE3688950T2 - Substituierte Chinolinderivate. - Google Patents

Substituierte Chinolinderivate.

Info

Publication number
DE3688950T2
DE3688950T2 DE86304820T DE3688950T DE3688950T2 DE 3688950 T2 DE3688950 T2 DE 3688950T2 DE 86304820 T DE86304820 T DE 86304820T DE 3688950 T DE3688950 T DE 3688950T DE 3688950 T2 DE3688950 T2 DE 3688950T2
Authority
DE
Germany
Prior art keywords
sub
lower alkyl
hydroxy
amino
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE86304820T
Other languages
English (en)
Other versions
DE3688950D1 (de
Inventor
Graham John Atwell
William Alexander Denny
Gordon William Rewcastle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenova Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Application granted granted Critical
Publication of DE3688950D1 publication Critical patent/DE3688950D1/de
Publication of DE3688950T2 publication Critical patent/DE3688950T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
DE86304820T 1985-06-24 1986-06-23 Substituierte Chinolinderivate. Expired - Fee Related DE3688950T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ212525A NZ212525A (en) 1985-06-24 1985-06-24 Nitrogen-containing heterocyclic compounds, and pharmaceutical compositions containing such

Publications (2)

Publication Number Publication Date
DE3688950D1 DE3688950D1 (de) 1993-10-07
DE3688950T2 true DE3688950T2 (de) 1994-03-17

Family

ID=19921254

Family Applications (1)

Application Number Title Priority Date Filing Date
DE86304820T Expired - Fee Related DE3688950T2 (de) 1985-06-24 1986-06-23 Substituierte Chinolinderivate.

Country Status (6)

Country Link
US (1) US4904659A (de)
EP (1) EP0206802B1 (de)
JP (1) JPH0764819B2 (de)
AT (1) ATE93853T1 (de)
DE (1) DE3688950T2 (de)
NZ (1) NZ212525A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084276A (en) * 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
IT1258315B (it) * 1992-04-10 1996-02-22 Recordati Chem Pharm Derivati del flavone
DE69329336D1 (de) * 1992-05-28 2000-10-05 Xenova Ltd Acridin carboxamide zur behandlung von krebs
US5696131A (en) * 1993-01-22 1997-12-09 Xenova Limited Treatment of cancers
AU4567193A (en) * 1992-07-10 1994-01-31 Laboratoires Glaxo S.A. Anilide derivatives
JP4603646B2 (ja) * 1999-11-15 2010-12-22 富士フイルムファインケミカルズ株式会社 新規なジピリジル誘導体
US20020121638A1 (en) * 2000-06-30 2002-09-05 Vladimir Grushin Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
WO2004089297A2 (en) 2003-04-02 2004-10-21 Suntory Pharmaceutical Research Laboratories, Llc Compounds and methods for treatment of thrombosis
WO2005118580A2 (en) * 2004-05-12 2005-12-15 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Tricyclic compounds as inhibitors of the hypoxic signaling pathway
WO2006034512A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
EA021938B1 (ru) * 2008-05-01 2015-10-30 Сертрис Фармасьютикалз, Инк. Хинолины и их аналоги в качестве модуляторов сиртуина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3704322A (en) * 1969-09-24 1972-11-28 Malesci S A S Inst Farmacobiol N-alkyl-n'-(1-naphthoyl) ethylene diamines
NZ201084A (en) * 1982-06-25 1985-10-11 New Zealand Dev Finance 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4567627A (en) * 1983-08-16 1986-02-04 W. W. Patterson Company Load binder apparatus
EP0172744A2 (de) * 1984-08-16 1986-02-26 Development Finance Corporation Of New Zealand Phenazincarboxamid-Verbindungen

Also Published As

Publication number Publication date
ATE93853T1 (de) 1993-09-15
JPS6248669A (ja) 1987-03-03
EP0206802B1 (de) 1993-09-01
JPH0764819B2 (ja) 1995-07-12
NZ212525A (en) 1989-02-24
EP0206802A2 (de) 1986-12-30
EP0206802A3 (en) 1988-07-13
DE3688950D1 (de) 1993-10-07
US4904659A (en) 1990-02-27

Similar Documents

Publication Publication Date Title
ATE93853T1 (de) Substituierte chinolinderivate.
ATE167473T1 (de) Sulfonamid-derivate
ES408565A1 (es) Procedimiento para la preparacion de diaminas ciclicas di- sustituidas en n, n.
KR850001171A (ko) 퀴놀린 화합물의 제조방법
IE43866L (en) Piperidine derivatives.
ATE60571T1 (de) Inden-analoga von mevalonolakton und ihre derivate.
SE429651B (sv) Forfarande for framstellning av alfa-fenylbensylidenaminosyraderivat med antikonvulsiv aktivitet
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
ES8304096A1 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
SE8603099L (sv) Distamycinderivat och forfarande for deras framstellning
FR2436132A1 (fr) Nouveaux derives d'acide para-(aryl(alkyl ou alcenyl)amino)-benzoique, et leur utilisation comme agents antilipidemiques
ATE37183T1 (de) Chinazolin- und isochinolin-derivate.
FI882477A0 (fi) >nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FR2356650A1 (fr) Nouveaux derives de pyrazolo(1,5-c)quinazoline et composes apparentes, utiles comme agents anti-allergiques
SE7706346L (sv) Bensaminderivat
FI841081A (fi) Bis-(piperazinyl- eller homopiperazinyl)-alkaner.
GB1255634A (en) Novel halophenylalkylene amines
IT1207057B (it) Policarbonati ramificati contenenti 2,4,6-tris(4'-idrossiaril)-ammino-s-triazine.
SE7609586L (sv) N-alkyldifenylaminer
YU198190A (sh) Diazabicikloaminske spojine in postopek za njihovo pripravo
GB1254345A (en) Alkali-soluble colour couplers
ES466826A1 (es) Procedimiento para la obtencion de derivados de acido benzo-hetero-cigliglioxilico.
ES381036A1 (es) Medicamentos analgesicos a base de n-(aroilalkil) n'-(alfa-nols) piperacinas y sus derivados, y procedimiento para su obtencion.
GB1463582A (en) Pyridine derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: XENOVA LTD., SLOUGH, BERKSHIRE, GB

8339 Ceased/non-payment of the annual fee